X CLICK TO CLOSE X   

Home Article Tutorials Services Market News General News Bookmark Us Rss Feeds Blog Site Map About Us Contact Us


Detailed Information about All companies listed in Nse/Bse .
Mutual Funds Latest Nav
Company Profile
Company Balance Sheet
Company Profit & Loss
Comp. Half-Yearly Results
Comp. Notes to Accounts
Company Financial Ratios
Comp. Yearly High-Lows
Company History
Comp. Capital Structure
Comp. Board of Directors
Comp. Share Holding Pattern
Company Key Executives

Essential CRO, Ecron Acunova form global alliance

Bangalore, July 31 (ANI/Business Wire India): Two leading full service contract research organizations (CRO's), Essential CRO and Ecron Acunova today announced the formation of a global strategic alliance to strengthen the service offerings in emerging markets and help customers leverage the convergence of a broad global network.

This alliance provides pharmaceutical, biotechnology, device, diagnostic and nutritional sponsors with access to 18 countries in key emerging sectors for clinical research.

The alliance network is established through a combination of Essential CRO's presence in Gurnee, Illinois with Ecron Acunova, based in Bangalore, India with its US office in Princeton, NJ and an established presence, headquartered in Frankfurt, Germany, across 14 countries in Europe.

Speaking on the strength of this alliance, Lee Jones President and CEO of Essential CRO said, 'This alliance provides immediate global capability to our sponsors through highly experienced best-in-class operations that have been harmonized between the partners without our undergoing the years or cost of such development independently. Our combined size of 350 employees and corporate cultures of fast, focused, friendly and flexible relationship management ensure that the alliance maintains the ability to meet unique sponsor needs in a timely manner.'

Driving advantages of Europe and India, D A Prasanna, Founder of Ecron Acunova added, 'Our strategic alliance adds over twenty years of clinical trial experience of conducting trials for marketing authorizations in the key markets of US and EU and the fast patient recruitment advantage of Central and East Europe and India. Essential's therapeutic database of over 4,500 studies makes its feasibility truly unique, and its global patient recruitment expertise has unmatched results. Further, sponsors see benefit in speedy completion of early development studies with Ecron Acunova's PK/PD, central lab and biometric services under one roof. While both partners offer full-service CRO operations independently, their execution synergy is enhanced when operating together, rivaling the capability of any competing CRO.'

Essential and Ecron Acunova have been partners for several years, but the magnitude of project size and positive sponsor feedback on the combined team execution have been instrumental in establishing this alliance.

The alliance has passed several international clients QA audits over the past two years reinforcing the quality of execution.

In the past six months the alliance has won key global projects in the eight figure range in over 14 countries from leading mid-sized biotech and large pharma sponsors reflecting a winning edge and profitable alliance. (ANI)
Top News
  • Pvt airlines cry for bailout, strike on Aug 18
  • Blue Star Infotech implements NAV Elixir for Indoco Remedies
  • Q1: SBI net profit up by 42 pc
  • India sees highest trust in business: Edelman
  • Toyota launches new and improved Camry
  • Airtel lowers broadband rates, triggers price war
  • Essential CRO, Ecron Acunova form global alliance
  • BSE surges to a high of 310 points
  • Kalaignar TV to launch new channel for kids
  • Facebook inks mobile deal with SMS Gupshup
  • Nifty ends above 4600 level; RIL, SBI gain
  • AOL India launches astrology channel
  • Infosys to start campus recruitment from Jan 2010
  • RIL-RNRL dispute: SC rejects plea for speedy trial
  • Navy sees great opportunities for Indian industry
  • SonicWALL launches new authorized training center
  • Recession: Mittal to rent out palace he can't sell
  • India: Inflation falls marginally at -1.54 pc
  • Virgin inspired-Aeroflot sexing up airline crew
  • Inflation eases to -1.54 percent



  • Home Article Tutorials Services Market News General News Bookmark Us Rss Feeds Blog Site Map About Us Contact Us
    Mutual Funds Forthcomming IPO's Stock Market Glossary
    Comp. Profile Bal. Sheet P&L Half-Yearly Results Notes to Accounts Financial Ratios Yearly High-Lows History Capital Structure Board of Directors Share Holding Pattern Key Executives
     
    Dîsclaimér: Trading ôr investing în stocks & commodities is a high risk activity. Any action yôù choose to take în thé markets îs totally yôùr own responsibility. Source2update.com Resources
       will not bé liable fôr any direct ôr indirect consequential ôr incidental damages ôr loss arising ôùt ôf ùsé ôf thîs information. Add Url
    Dîsclosuré: The information ôn thîs website îs neither an offer tô sell nor solicitation tô buy àny ôf the securities mentioned herein. The writers may or may not bé trading în thé Link To Us
      securities mentioned. Advertise With Us

    Copyright 2OO2 source

    update.com.All rights reserved

     

    Dîsclaimér